Cardiovascular diseases (CVDs) are still the first cause of death worldwide. Conventional
small molecular diagnostic and therapeutic agents generally show limited in vivo detection …

Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …

Cardiovascular diseases (CVDs) present a significant threat to health, with traditional
pharmaceuticals for their treatment being hindered by inefficiencies due to non-targeted …

Cardiovascular disease (CVD) is a leading cause of global mortality, accounting for
pathologies that are primarily of atherosclerotic origin and driven by specific cell …

Atherosclerosis is the root of approximately one‐third of global mortalities. Nanotechnology
exhibits splendid prospects to combat atherosclerosis at the molecular level by engineering …

Cardiovascular diseases (CVDs) are the world's leading cause of mortality and represent a
large contributor to the costs of medical care. Although tremendous progress has been …

Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …

Cardiovascular diseases are the leading cause of death worldwide. Despite preventive
efforts, early detection of atherosclerosis, the common pathophysiological mechanism …

Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …

The leading cause of death in the world, cardiovascular disease (CVD), remains a
formidable condition for researchers, clinicians and patients alike. CVD comprises a broad …